CIMT 15th Anniversary Symposium
May 10-11, 2017
The 15th meeting of the Association for Cancer Immunotherapy is an anniversary members symposium that will celebrate the work of cancer immunotherapy research through scientific presentations and a special awards dinner. The symposium will bring together leading international experts on adoptive cell theapy, cancer epigenetics, antibodies, cancer vaccination and immunoguiding. They will present an overview of past and present developments and will discuss clinical and translational developments.
Sign-in and badge pickup
CIP Immunoguiding Seminar
Sven Brandau, University Hospital Essen
"Neutrophils and MDSC in cancer: Immunomonitoring and clinical relevance"
Hergen Spits, AIMM Therapeutics
"Innate Lymphoid Cells, ILC"
Lunch, food and beverages
at Frankfurter Hof
CIP Steering Committee, Marij Welters, Sine Reker Hadrup
"CIP activities summary: ongoing projects and planned activities"
Tanja de Gruijl, VU University Medical Center Amsterdam
“Phenotypic and functional immune profiling of sentinel lymph nodes: clues for early clinical intervention”
Angela M. Krackhardt, Technical University Munich
"Immunopeptidomics & T-cell trafficking"
CMT Members Meeting
General Members Assembly of the Asscociation for Cancer Immunotherapy
Christoph Huber CIMT
Institut Gustave Roussy
“Immune-checkpoint inhibitors from advanced disease to the adjuvant setting”
Lifetime Achievement Award Ceremony and Reception
Speeches, drinks and food
Clinical Translation, Cancer Vaccination
Christian Ottensmeier, University of Southampton
"Clinical Translation of Immunotherapy. Where do we stand?"
Carl Figdor, Radboud University
"Synthetic dendritic cells as 21st century cancer vaccines"
Ugur Sahin, BioNTech
"mRNA based cancer immunotherapy"
Coffee and snacks
Adoptive T-Cell Therapy, Innate Immunity, Cancer Epigenetics
Johanna Olweus, Oslo University Hospital Radiumhospitalet/Jebsen Center for Cancer Immunotherapy
"Adoptive T cell therapy - the quest for anti-tumor missiles"
Eric Vivier, Centre d'Immunologie de Marseille-Luminy
"Innate immunity in cancer immunotherapy – status & perspectives"
Manel Esteller Badosa, University of Barcelona
"Cancer epigenetics: From knowledge to applications"
food and drinks
Antibodies, Helper T-Cell Physiology
Özlem Türeci, Ci3-Cluster for Individualized Immune Intervention
"Antibody based cancer therapy"
Vincenzo Cerundolo, University of Oxford
"Amino acid degrading enzymes and their role in tumour immune escape mechanisms"
Olivier Lantz, Institut Curie
"CD4 T cells in anti-tumor immunity"
Coffee and snacks
HLA Ligandome, Clinical Immunomonitoring
Stefan Stevanovic, University of Tübingen
"Cancer HLA ligandome and multiepitope vaccination"
Patrick Hwu, MD Anderson Cancer Center
Marij Welters, Leiden University Medical Center
"Clinical Immunomonitoring. Progress and relevance"